Recombinant
RabMAb

Anti-eIF4E antibody [Y448] (ab33766)

Publishing research using ab33766? Please let us know so that we can cite the reference in this datasheet.

ab33766 has been referenced in 2 publications.

  • Tamarkin-Ben-Harush A  et al. Cap-proximal nucleotides via differential eIF4E binding and alternative promoter usage mediate translational response to energy stress. Elife 6:N/A (2017). PubMed: 28177284
  • Wang J  et al. Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget 6:24075-91 (2015). IP . PubMed: 26124182

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up